Dimensional Fund Advisors
HUMA icon

Dimensional Fund Advisors’s Humacyte HUMA Stock Holding History

Dimensional Fund Advisors’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-62,237
Closed -$177K – 3412
2023
Q4 		$177K Hold
62,237
– – ﹤0.01% 3211
2023
Q3 		$182K Buy
+62,237
New +$206K ﹤0.01% 3228

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Dimensional Fund Advisors's HUMA Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Humacyte (HUMA) in Q1 2024, closing a stake of 62,237 shares — an estimated $177K sold.

Dimensional Fund Advisors first reported a position in HUMA in Q3 2023 and held it in 2 quarters. The position peaked at $182K in Q3 2023. 96 funds tracked by Wall St. Rank hold HUMA as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Humacyte position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 62,237 Humacyte shares in Q1 2024, an estimated $177K.
  • Dimensional Fund Advisors first reported a position in Humacyte in Q3 2023 and held it in 2 quarters.
  • Dimensional Fund Advisors's Humacyte position peaked at $182K in Q3 2023.
  • 96 funds tracked by Wall St. Rank held Humacyte as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.